Literature DB >> 11195509

Determination of mycophenolic acid and mycophenolate mofetil by high-performance liquid chromatography using postcolumn derivatization.

U D Renner1, C Thiede, M Bornhäuser, G Ehninger, H M Thiede.   

Abstract

An efficient method to lower the optical detection limit is described using the displacement of an absorption and emission band of an analyte after a polarity change in different solvents. This solvatochromic effect was used in a RP-HPLC assay for the fluorescence detection of mycophenolic acid (6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid, MPA) and the prodrug mycophenolate mofetil (MMF), the N-(2-hydroxyethyl)morpholino ester of MPA. The rational to use fluorescence detection is based on the behavior of MMF and MPA, which fluoresce in a basic medium (pH >9.5). Following a simple protein precipitation, the analytes were separated in an isocratic RP-HPLC system. The postcolumn generation of the phenolate anions of MPA and MMF was achieved by addition of an aqueous sodium hydroxide solution regulated by a newly developed continuous-flow liquid control system. MPAG, not directly accessible for fluorescence detection, was analyzed after enzymatic deglucuronidation to MPA. Compared to published quantification limits for MPA and MMF by UV detection, this method is more than 100-fold more sensitive, with a lower limit of quantification of 45 fmol for both MPA and MMF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11195509     DOI: 10.1021/ac0006730

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

1.  Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.

Authors:  Luisa Giaccone; Jeannine S McCune; Michael B Maris; Theodore A Gooley; Brenda M Sandmaier; John T Slattery; Scott Cole; Richard A Nash; Rainer F Storb; George E Georges
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

2.  Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.

Authors:  Cara L McDermott; Brenda M Sandmaier; Barry Storer; Hong Li; Donald E Mager; Michael J Boeckh; Meagan J Bemer; Jennifer Knutson; Jeannine S McCune
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-06       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.